REGISTERED NUMBER: 09355532 (England and Wales)

Unaudited Financial Statements

For The Period 1 August 2023 to 31 December 2024

for

Adorial Pharma Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Ms E Blaney

Mr N Ray

REGISTERED OFFICE:

Part Ground Floor

Broadhurst House

56 Oxford Street

Manchester

M1 6EU

REGISTERED NUMBER:

09355532 (England and Wales)

ACCOUNTANTS:

Fact3

3 Hardman Square

Spinningfields

Manchester

M3 3EB

TOTAL ASSETS LESS CURRENT LIABILITIES

-

-

CREDITORS

Amounts falling due after more than one year

4

4,986

4,986

NET LIABILITIES

(4,986

)

(4,986

)

CAPITAL AND RESERVES

Called up share capital

1

1

Share premium

99

99

Retained earnings

(5,086

)

(5,086

)

(4,986

)

(4,986

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2025 and were signed on its behalf by:

Ms E Blaney - Director

1.	STATUTORY INFORMATION

Adorial Pharma Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

In previous years the financial statements have been prepared on a going concern basis. However the Company has now ceased trading. Accordingly, the directors have not prepared the financial statements on a going concern basis. There is no impact on the assets or liabilities of the Company as a result of this change.

The company was dormant throughout the current period and previous year.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - NIL).

4.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2024

2023

£

£

Amounts owed to group undertakings

4,986

4,986

5.	ULTIMATE CONTROLLING PARTY

The Company's immediate parent company is Adorial Ltd and its ultimate parent company is C4X Discovery Holdings plc, a company registered in England and Wales. The smallest and largest group within which the results of the Company are consolidated is that headed by C4X Discovery Holdings plc. Copies of the C4X Discovery Holdings plc consolidated accounts can be obtained from:

C4X Discovery Holdings plc

Manchester One

53 Portland Street

Manchester

M1 3LD